Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning balance, Shares at May. 31, 2022   359.9      
Beginning balance at May. 31, 2022 $ 3,085.2 $ 3.6 $ 1,545.9 $ 1,669.6 $ (133.9)
Net income 739.5     739.5  
Unrealized gains (losses) on securities, net of tax benefit (61.3)       (61.3)
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] (0.1)       (0.1)
Cash dividends declared (569.6)     (569.6)  
Stock-based compensation costs 29.7   29.7    
Foreign currency translation adjustment (3.0)       (3.0)
Activity related to equity-based plans, Shares   0.6      
Activity related to equity-based plans (15.1) $ 0.0 13.0 (28.1)  
Ending balance, Shares at Nov. 30, 2022   360.5      
Ending balance at Nov. 30, 2022 3,205.3 $ 3.6 1,588.6 1,811.4 (198.3)
Beginning balance, Shares at Aug. 31, 2022   360.4      
Beginning balance at Aug. 31, 2022 3,137.4 $ 3.6 1,568.9 1,736.3 (171.4)
Net income 360.3     360.3  
Unrealized gains (losses) on securities, net of tax benefit (31.8)       (31.8)
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) 0.0       0.0
Cash dividends declared (284.9)     (284.9)  
Stock-based compensation costs 15.3   15.3    
Foreign currency translation adjustment 4.9       4.9
Activity related to equity-based plans, Shares   0.1      
Activity related to equity-based plans 4.1 $ 0.0 4.4 (0.3)  
Ending balance, Shares at Nov. 30, 2022   360.5      
Ending balance at Nov. 30, 2022 $ 3,205.3 $ 3.6 1,588.6 1,811.4 (198.3)
Beginning balance, Shares at May. 31, 2023 360.5 360.5      
Beginning balance at May. 31, 2023 $ 3,493.2 $ 3.6 1,626.4 2,023.1 (159.9)
Net income 811.9     811.9  
Unrealized gains (losses) on securities, net of tax benefit (9.1)       (9.1)
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] 0.0       0.0
Cash dividends declared (641.9)     (641.9)  
Repurchases of common shares, Shares [2]   (1.5)      
Repurchases of common shares [2] (169.2) $ 0.0 (6.2) (163.0)  
Stock-based compensation costs 30.7   30.7    
Foreign currency translation adjustment 1.8       1.8
Activity related to equity-based plans, Shares   0.8      
Activity related to equity-based plans $ 7.0 $ 0.0 27.7 (20.7)  
Ending balance, Shares at Nov. 30, 2023 359.8 359.8      
Ending balance at Nov. 30, 2023 $ 3,524.4 $ 3.6 1,678.6 2,009.4 (167.2)
Beginning balance, Shares at Aug. 31, 2023   361.2      
Beginning balance at Aug. 31, 2023 3,587.8 $ 3.6 1,666.4 2,100.9 (183.1)
Net income 392.7     392.7  
Unrealized gains (losses) on securities, net of tax benefit 14.8       14.8
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] 0.0       0.0
Cash dividends declared (320.5)     (320.5)  
Repurchases of common shares, Shares [2]   (1.5)      
Repurchases of common shares [2] (169.2) $ 0.0 (6.2) (163.0)  
Stock-based compensation costs 14.7   14.7    
Foreign currency translation adjustment 1.1       1.1
Activity related to equity-based plans, Shares   0.1      
Activity related to equity-based plans $ 3.0 $ 0.0 3.7 (0.7)  
Ending balance, Shares at Nov. 30, 2023 359.8 359.8      
Ending balance at Nov. 30, 2023 $ 3,524.4 $ 3.6 $ 1,678.6 $ 2,009.4 $ (167.2)
[1] Reclassification adjustments out of accumulated other comprehensive loss for realized gains/(losses), net of tax, on the sale of AFS securities are reflected in interest on funds held for clients and other expense, net on the Consolidated Statements of Income and Comprehensive Income.
(2)
The Company maintains a program to repurchase up to $400.0 million of its common stock, with authorization expiring January 31, 2024. The purpose of this program is to manage common stock dilution.
[2] The Company maintains a program to repurchase up to $400.0 million of its common stock, with authorization expiring January 31, 2024. The purpose of this program is to manage common stock dilution.